abpi

UK research cannot rest on its laurels, warns ABPI

October 21, 2011
Medical Communications, Research and Development ABPI, NHS, R&D

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …

Abbott

Abbott to split into two separate companies

October 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …

GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011
Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …

Herceptin image

Injectable Herceptin proves its worth

October 20, 2011
Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …

Medical Devices: Harmonisation of Requirements for Address of Manufacturer

October 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …

Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline

October 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …

malaria vaccine trial

GSK malaria vaccine cuts disease risk by half

October 19, 2011
Research and Development malaria, malaria vaccine

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …

European judge rules against stem cell patents

October 19, 2011
Research and Development Stem cells, patents

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …

NHS hospital prescribing costs jump

October 19, 2011
Sales and Marketing hospital spending, prescribing

New and expensive treatments have driven up NHS prescribing costs in English hospitals, according to a new report. IMS Health …

ralf_huss

German biotech Apceth appoints Prof. Ralf Huss

October 19, 2011
Research and Development appointment, research and development

Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …

iPad graphic

Digital Pharma: It’s not about the brand website

October 19, 2011
Sales and Marketing Digital Pharma blog

The last few years have seen an explosion of interest in digital marketing in the pharma sector, reflecting the wider …

Byetta approved for use with insulin

October 19, 2011
Amylin, GLP-1, diabetes, lilly

The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …

Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011
Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …

KV Pharma sues ex-chief exec to recoup compensation package

October 18, 2011
Ethex, KV Pharma, Marc Hermelin

US drugmaker KV Pharmaceutical is suing its former chief executive Marc Hermelin to avoid paying him a retirement and compensation …

GSK planning job cuts at Quebec vaccines plant

October 18, 2011
Manufacturing and Production Canada, GSK, Quebec, vaccines

GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …

Angel Bio plans joint venture with Russian drugmaker

October 18, 2011
Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics

UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …

Byetta

NICE recommends Lilly’s long-acting Bydureon

October 18, 2011
Sales and Marketing Bydureon, NICE, diabetes

NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …

Professor Malcolm Grant

Grant nominated for key NHS Commissioning Board post

October 18, 2011
Commissioning Board, Malcolm Grant, NHS, Nicholson

The government has named its choice for one of the key roles at the new NHS Commissioning Board. Professor Malcolm …

EMA resources stretched by Mediator scandal

October 18, 2011
Research and Development, Sales and Marketing EMA, Mediator

The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …

Pharma Brands – join the live discussion on Twitter

October 17, 2011
Sales and Marketing branding, brands

Do pharma marketers need to kill off the ‘smiley happy people’ and update their approach to branding?  InPharm will host …

The Gateway to Local Adoption Series

Latest content